Activating Compound | Comment | Organism | Structure |
---|---|---|---|
4,5-bis(benzylamino)-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile | about 15% increase of activity at 10 nM | Homo sapiens | |
4,5-bis(benzylamino)-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile | about 30% increase of activity at 10 nM | Canis lupus familiaris | |
4-(benzylamino)-5-[(3-phenylpropyl)amino]-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile | about 15% increase of activity at 10 nM | Homo sapiens | |
4-(benzylamino)-5-[(3-phenylpropyl)amino]-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile | about 30% increase of activity at 10 nM | Canis lupus familiaris | |
4-(benzylamino)-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | - |
Homo sapiens | |
4-(benzylamino)-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | - |
Canis lupus familiaris | |
4-anilino-5-(benzylamino)-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile | 15% increase of activity at 10 nM | Homo sapiens | |
4-anilino-5-(benzylamino)-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile | 25% increase of activity at 10 nM | Canis lupus familiaris | |
4-anilino-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | - |
Homo sapiens | |
4-anilino-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | - |
Canis lupus familiaris | |
4-[(2-phenylethyl)amino]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | - |
Homo sapiens | |
4-[(2-phenylethyl)amino]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | - |
Canis lupus familiaris | |
4-[(3-phenylpropyl)amino]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | - |
Homo sapiens | |
4-[(3-phenylpropyl)amino]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | - |
Canis lupus familiaris | |
5-(2-phenylethyl)-4-[(2-phenylethyl)amino]-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile | about 20% increase of activity at 10 nM | Homo sapiens | |
5-(2-phenylethyl)-4-[(2-phenylethyl)amino]-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile | about 43% increase of activity at 10 nM | Canis lupus familiaris | |
5-(2-phenylethyl)-4-[(3-phenylpropyl)amino]-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile | about 20% increase of activity at 10 nM | Homo sapiens | |
5-(2-phenylethyl)-4-[(3-phenylpropyl)amino]-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile | about 45% increase of activity at 10 nM | Canis lupus familiaris | |
5-(benzylamino)-4-(methylamino)-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile | about 10% increase of activity at 10 nM | Homo sapiens | |
5-(benzylamino)-4-(methylamino)-5H-pyrrolo[3,2-d]pyrimidine-7-carbonitrile | about 40% increase of activity at 10 nM | Canis lupus familiaris | |
6-(4-benzylpiperazin-1-yl)-7H-purine | 25% increase of activity at 10 nM | Canis lupus familiaris | |
6-(4-benzylpiperazin-1-yl)-7H-purine | about 20% increase of activity at 10 nM | Homo sapiens | |
6-(4-phenylpiperazin-1-yl)-7H-purine | about 35% increase of activity at 10 nM | Canis lupus familiaris | |
6-(4-phenylpiperazin-1-yl)-7H-purine | about 7% increase of activity at 10 nM | Homo sapiens | |
6-[4-(2-phenylethyl)piperazin-1-yl]-7H-purine | about 30% increase of activity at 10 nM | Canis lupus familiaris | |
6-[4-(2-phenylethyl)piperazin-1-yl]-7H-purine | about 7% increase of activity at 10 nM | Homo sapiens | |
6-[4-(diphenylmethyl)piperazin-1-yl]-7H-purine | 25% increase of activity at 10 nM | Homo sapiens | |
6-[4-(diphenylmethyl)piperazin-1-yl]-7H-purine | more than 50% increase of activity at 10 nM | Canis lupus familiaris |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
4-[4-(2-phenylethyl)piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | complete inhibition at 10 nM | Canis lupus familiaris | |
4-[4-(2-phenylethyl)piperazin-1-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile | complete inhibition at 10 nM | Homo sapiens | |
cyclosporine A | - |
Canis lupus familiaris | |
cyclosporine A | - |
Homo sapiens | |
Ko143 | - |
Canis lupus familiaris | |
Ko143 | - |
Homo sapiens | |
verapamil | - |
Canis lupus familiaris | |
verapamil | - |
Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + H2O + glutathione-S-conjugate[side 1] | Homo sapiens | - |
ADP + phosphate + glutathione-S-conjugate[side 2] | - |
? | |
ATP + H2O + glutathione-S-conjugate[side 1] | Canis lupus familiaris | - |
ADP + phosphate + glutathione-S-conjugate[side 2] | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Canis lupus familiaris | Q6UR05 | - |
- |
Homo sapiens | P33527 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
H-69AR cell | - |
Homo sapiens | - |
MDCK II cell | - |
Canis lupus familiaris | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + H2O + glutathione-S-conjugate[side 1] | - |
Homo sapiens | ADP + phosphate + glutathione-S-conjugate[side 2] | - |
? | |
ATP + H2O + glutathione-S-conjugate[side 1] | - |
Canis lupus familiaris | ADP + phosphate + glutathione-S-conjugate[side 2] | - |
? | |
ATP + H2O + S-(calcein acetoxymethyl ester)glutathione[side 1] | - |
Homo sapiens | ADP + phosphate + S-(calcein acetoxymethyl ester)glutathione[side 2] | - |
? | |
ATP + H2O + S-(calcein acetoxymethyl ester)glutathione[side 1] | - |
Canis lupus familiaris | ADP + phosphate + S-(calcein acetoxymethyl ester)glutathione[side 2] | - |
? | |
ATP + H2O + S-(daunorubicin)glutathione[side 1] | - |
Homo sapiens | ADP + phosphate + S-(daunorubicin)glutathione[side 2] | - |
? | |
ATP + H2O + S-(daunorubicin)glutathione[side 1] | - |
Canis lupus familiaris | ADP + phosphate + S-(daunorubicin)glutathione[side 2] | - |
? |
Synonyms | Comment | Organism |
---|---|---|
ABCC1 | - |
Homo sapiens |
ABCC1 | - |
Canis lupus familiaris |
MRP1 | - |
Homo sapiens |
MRP1 | - |
Canis lupus familiaris |
multidrug resistance-associated protein 1 | - |
Homo sapiens |
multidrug resistance-associated protein 1 | - |
Canis lupus familiaris |